Mid-Regional Pro-Atrial Natriuretic Peptide and Pro-Adrenomedullin Testing for the Diagnostic and Prognostic Evaluation of Patients With Acute Dyspnoea

Study Questions:

Does mid-regional pro-atrial natriuretic peptide (MR-proANP) or adrenomedulin (MR-proADM) add diagnostic or prognostic value over amino-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients presenting to the emergency room with dyspnea?